Gamma‐irradiated Newcastle disease virus: an alternative inactivated oncolytic virotherapy
Immunology & Cell Biology · 2026-05 · 104 (5) · 473-484
DOI: 10.1111/imcb.70107 ↗At a glance
Journal article in Immunology & Cell Biology, published online on 2026-04-05. Written by Eve V Kennedy and 10 co-authors. Institution: Research Centre for Infectious Diseases, School of Biological Sciences, Adelaide University, Adelaide, SA, Australia. Major MEDLINE topics: Newcastle disease virus, Oncolytic Virotherapy, Gamma Rays, Oncolytic Viruses. 46 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Newcastle disease virus (NDV) has been investigated as an oncolytic virus in many clinical trials, demonstrating the ability of NDV to treat a range of different cancers. However, research with NDV is hindered by biosecurity risks associated with live NDV. In addition, NDV is an important poultry pathogen that is associated with widespread livestock losses and a large economic burden. While live and chemically inactivated NDV vaccines are available, they have limited efficacy and there is a need for alternative vaccines. In this study, we inactivated NDV using γ‐irradiation and tested the structural integrity, immunogenicity, and oncolytic activity of γ‐NDV using in vitro and in vivo models. Our data illustrate that the overall virion structure and protein function of γ‐NDV are well maintained. However, we did not detect neutralizing antibody responses after intramuscular or subcutaneous γ‐NDV administration in mice. While these data do not directly support the use of γ‐NDV as a vaccine candidate, our data show that γ‐NDV retained its ability to kill a range of different cancer cells in vitro , suggesting γ‐NDV may be a potential cancer therapeutic agent. To test this, γ‐NDV was trialed as an oncolytic therapy in a murine melanoma model. This revealed that γ‐NDV administration outperformed live NDV in terms of reduced tumor growth and overall survival. While further investigation is required to address the suitability of γ‐NDV as a poultry vaccine, our data indicate that γ‐irradiation may be a suitable inactivation method for the development of a highly effective inactivated oncolytic virotherapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Research Centre for Infectious Diseases, School of Biological Sciences, Adelaide University, Adelaide, SA, Australia.
- Australian Nuclear Science and Technology Organisation, Lucas Heights, NSW, Australia.
- School of Animal and Veterinary Sciences, Adelaide University, Roseworthy, SA, Australia.
ORCID profiles: Yimin Chuah
Cite
APA
Kennedy, E. V., Chuah, Y., Mostafa, A. H., Gates, C. J., Foeng, J., Norton, T. S., McColl, S. R., Comerford, I., Davies, J. B., Hemmatzadeh, F., & Alsharifi, M. (2026). Gamma‐irradiated Newcastle disease virus: an alternative inactivated oncolytic virotherapy. Immunology & Cell Biology, 104(5), 473-484. https://doi.org/10.1111/imcb.70107
Vancouver
Kennedy EV, Chuah Y, Mostafa AH, Gates CJ, Foeng J, Norton TS, et al. Gamma‐irradiated Newcastle disease virus: an alternative inactivated oncolytic virotherapy. Immunology & Cell Biology. 2026;104(5):473-484. doi:10.1111/imcb.70107
BibTeX
@article{Kennedy2026,
author = {Kennedy, Eve V and Chuah, Yimin and Mostafa, Amal H and Gates, Chloe J and Foeng, Jade and Norton, Todd S and McColl, Shaun R and Comerford, Iain and Davies, Justin B and Hemmatzadeh, Farhid and Alsharifi, Mohammed},
title = {Gamma‐irradiated Newcastle disease virus: an alternative inactivated oncolytic virotherapy},
journal = {Immunology & Cell Biology},
year = {2026},
volume = {104},
number = {5},
pages = {473--484},
doi = {10.1111/imcb.70107}
}
EUVIMED